Literature DB >> 6084614

The characterization and uses of monoclonal antibodies to respiratory syncytial virus.

E J Stott, M H Bew, G Taylor, J Jebbett, A P Collins.   

Abstract

Fifteen hybridomas secreting monoclonal antibodies against respiratory syncytial virus (RSV) have been produced. Three react with nucleoprotein (MW 42 000 daltons), 1 with phosphoprotein (MW 36 000 daltons), 1 with a larger protein (MW 60 000 daltons) and 10 with the fusion glycoprotein (MW 46 000 + 22 000 daltons). By immunofluorescent staining of infected cells, 5 monoclonal antibodies bind to cytoplasmic inclusions and the remainder give diffuse cytoplasmic fluorescence. Virus infectivity is neutralized by two monoclonal antibodies. Thirteen react with both bovine and human strains of RSV, two fail to react with three human strains. The antibodies have been used to induce passive protection in mice against challenge with RSV and to purify viral components on immunoadsorbent columns.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6084614

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  8 in total

1.  Comparison of caprine, human and bovine strains of respiratory syncytial virus.

Authors:  M Trudel; F Nadon; C Simard; F Bélanger; R Alain; C Séguin; G Lussier
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

2.  Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.

Authors:  M Trudel; E J Stott; G Taylor; D Oth; G Mercier; F Nadon; C Séguin; C Simard; M Lacroix
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  A comparison of diagnostic methods for the detection of bovine respiratory syncytial virus in experimental clinical specimens.

Authors:  K West; J Bogdan; A Hamel; G Nayar; P S Morley; D M Haines; J A Ellis
Journal:  Can J Vet Res       Date:  1998-10       Impact factor: 1.310

4.  Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice.

Authors:  A M King; E J Stott; S J Langer; K K Young; L A Ball; G W Wertz
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

5.  RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology.

Authors:  G A Storch; C S Park; D E Dohner
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

6.  Modulation of the transcription factor NF-κB in antigen-presenting cells by bovine respiratory syncytial virus small hydrophobic protein.

Authors:  Nicola Pollock; Geraldine Taylor; Fatoumatta Jobe; Efrain Guzman
Journal:  J Gen Virol       Date:  2017-07-17       Impact factor: 3.891

Review 7.  The antiviral activity of antibodies in vitro and in vivo.

Authors:  P W Parren; D R Burton
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

Review 8.  Antibody development for preventing the human respiratory syncytial virus pathology.

Authors:  Jorge A Soto; Nicolás M S Gálvez; Gaspar A Pacheco; Susan M Bueno; Alexis M Kalergis
Journal:  Mol Med       Date:  2020-04-17       Impact factor: 6.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.